Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Ovarian Neoplasms 1Neoplasms 1Lymphoma, Follicular 1Genetic Predisposition to Disease 1Generalized Anxiety Disorder 1Fanconi Anemia, Complementation Group D1 1Colorectal Neoplasms 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 22Blood Specimen Collection 13niraparib 8Cytoreduction Surgical Procedures 8Hyperthermic Intraperitoneal Chemotherapy 7Interviews as Topic 6Immunohistochemistry 6olaparib 5Psychiatric Rehabilitation 5Polymerase Chain Reaction 5Magnetic Resonance Spectroscopy 5Data Collection 5Carboplatin 5Amplified Fragment Length Polymorphism Analysis 5liposomal doxorubicin 4Geriatric Assessment 4Bevacizumab 41-dodecylpyridoxal 4Ultrasonography 3Trabectedin 3Therapeutics 3Poly(ADP-ribose) Polymerase Inhibitors 3Phlebotomy 3Observation 3Neoadjuvant Therapy 3Microarray Analysis 3Laparoscopy 3Gene Expression Profiling 3Flow Cytometry 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Ovarian Neoplasms × Cognitive Behavioral Therapy × Clear all
NCT03889171 2019-03-28

PSICOM

University Hospital, Montpellier

Completed
200 enrolled
BreastClassical hematologyGastrointestinalGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡